These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8892676)
1. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein. Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676 [TBL] [Abstract][Full Text] [Related]
2. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329 [TBL] [Abstract][Full Text] [Related]
3. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Kim CN; Wang X; Huang Y; Ibrado AM; Liu L; Fang G; Bhalla K Cancer Res; 1997 Aug; 57(15):3115-20. PubMed ID: 9242435 [TBL] [Abstract][Full Text] [Related]
6. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016 [TBL] [Abstract][Full Text] [Related]
7. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Ponnathpur V; Ibrado AM; Reed JC; Ray S; Huang Y; Self S; Bullock G; Nawabi A; Bhalla K Clin Cancer Res; 1995 Nov; 1(11):1399-406. PubMed ID: 9815937 [TBL] [Abstract][Full Text] [Related]
8. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780 [TBL] [Abstract][Full Text] [Related]
9. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Ibrado AM; Liu L; Bhalla K Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280 [TBL] [Abstract][Full Text] [Related]
10. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2. Hedley DW; McCulloch EA Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994 [TBL] [Abstract][Full Text] [Related]
11. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273 [TBL] [Abstract][Full Text] [Related]
13. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells]. Lei XY; Zhang H; He DM Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735 [TBL] [Abstract][Full Text] [Related]
14. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60]. Zhou J; Chen Y; Li C Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072 [TBL] [Abstract][Full Text] [Related]
15. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039 [TBL] [Abstract][Full Text] [Related]
16. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells. Bhalla K; Ibrado AM; Bradt JE; Ray S; Huang Y; Tang C; Nawabi A; Hoffman R Leukemia; 1995 Nov; 9(11):1851-6. PubMed ID: 7475274 [TBL] [Abstract][Full Text] [Related]
17. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Konopleva M; Konoplev S; Hu W; Zaritskey AY; Afanasiev BV; Andreeff M Leukemia; 2002 Sep; 16(9):1713-24. PubMed ID: 12200686 [TBL] [Abstract][Full Text] [Related]
18. 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation. Ray S; Ponnathpur V; Huang Y; Tang C; Mahoney ME; Ibrado AM; Bullock G; Bhalla K Cancer Chemother Pharmacol; 1994; 34(5):365-71. PubMed ID: 7915211 [TBL] [Abstract][Full Text] [Related]
19. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Tang C; Willingham MC; Reed JC; Miyashita T; Ray S; Ponnathpur V; Huang Y; Mahoney ME; Bullock G; Bhalla K Leukemia; 1994 Nov; 8(11):1960-9. PubMed ID: 7526093 [TBL] [Abstract][Full Text] [Related]
20. [Effect of nimodipine on mechanisms of HL-60 cell apoptosis induced by cytarabine]. Sun LR; Gao BC; Pang XY; Lu Y; Li XR; Song AQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):72-5. PubMed ID: 17490525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]